The Drugs Controller General of India (DCGI) has directed the drugs controllers of all States and Union Territories to keep a strict vigil on the sale and distribution of falsified versions of two drugs, liver medication Defitelio and Takeda's cancer drug Adcetris (injection), following alerts issued by the World Health Organization (WHO).
(For top health news of the day, subscribe to our newsletter Health Matters)
In an advisory issued on September 5, the DCGI said the WHO has issued a safety alert identified with multiple falsified versions of Adcetris injection 50 mg manufactured by Takeda Pharmaceutical Company Limited, identified in four different countries including India.
